Patient Reported Outcomes in Adults With Pediatric-onset Hypophosphatasia Treated With Strensiq® (Asfotase Alfa)
Clinical trial NCT04195763 · COMPLETED
Trial details
- NCT number
- NCT04195763
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-06
- Primary completion
- 2024-04-12
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.